Диссертация (1154809), страница 25
Текст из файла (страница 25)
2000;6:32-35.137. Piccoli A. Whole body-single frequency bioimpedance. Contrib Nephrol.2005; 149: 150-61.138. Piccoli A.; Italian CAPD-BIA Study Group. Bioelectric impedance vectordistribution in peritoneal dialysis patients with different hydration status. Kidney Int.2004 Mar; 65(3): 1050-63.139. Piccolli A., Bioelectric impedance measurement for fluid statusassessment // Contributions to nephrologhy. – 2010. –Vol. 164 – P.143-152.140.
Piccolli A., Plebani M., Codognotto M., et al. Differentiation of cardiacand noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA) //Journal of cardiac failure. – 2012. –Vol, № 3–P.226-232.141. Publication Committee for the VMAC Investigators (Vasodilatation in theManagement of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment ofdecompensated congestive heart failure, a randomized controlled trial.
J. Am. Med.Assoc., 2002, 287, 1531-1540.142. Ribas N., Nescolarde L., Domingo M. Longitudinal and TransversalBioimpedance Measurementsin Addition to Diagnosis of Heart Failure.International Conference on Electrical Bioimpedance University of Florida,149Gainesville, FL April 4 - 8, 2010.143. Ridker PM, Buring JE, Rifai N, Cook NR.
Development and validation ofimproved algorithms for the assessment of global cardiovascular risk in women: theReynolds Risk Score. JAMA 2007; 297(6):611–619.144. Sackner-Bernstein J. What is heart failure and what are the treatmentoptions Complex questions. In: Hayes DL, Wang PJ, Sackner-Bernstein J,Asirvatham SJ, eds.
Resynchronization and Defibrillation for Heart Failure: APractical Approach. Oxford, England: Blackwell Publishing; 2004:1-2.145. Sageman WS, Amundson DE. Thoracic electrical bioimpedancemeasurement of cardiac output in postaortocoronary bypass patients. Crit Care Med1993; 21:1139-42.146.
Sageman WS, Riffenburgh RH, Spiess BD. Equivalence of bioimpedanceand thermodilution in measuring cardiac index after cardiac surgery. J CardiothoracVasc Anesth 2002; 16:8-14.147. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a riskfactor for development of cardiovascular disease: a statement from the AmericanHeart Association Councils on Kidney in Cardiovascular Disease, High BloodPressure Research, Clinical Cardiology, and Epidemiology and Prevention.Hypertension 2003; 42: 1050—65.148. Segal K.R., Gutin B., Presta E., Wang J., et al.
Estimation of human bodycomposition by electrical impedance methods: acomparative study // J. Appl.Physiol. - 1985. - Vol. 58, № 5. - P. 1565-1571.149. Selberg O., Selberg D. Norms and correlates of bioimpedance phase angelin healthy human subjects, hospitalized patients, and patients with liver cirrhosis//Eur. J. Appl. Physiol.
2002. V. 86. P. 509–516.150. Shochat M., Charach G., Meyler S., et al. Internal thoracic impedancemonitoring: a novel method for the preclinical detection of acute heart failure.Cardiovasc Revasc Med. 2006; 7: 41-45.151. Small R.S. Integrating device-based monitoring into clinical practice:insights from a large heart failure clinic.
Am J Cardiol. May 21, 2007; 99 (10A):15017G-22G.152. Sohal M., S.G. Duckett, X. Zhuang et al. A prospective evaluation ofcardiovascular magnetic resonance measures of dyssynchrony in the prediction ofresponse to cardiac resynchronization therapy // Cardiovasc. Magn. Reson. – 2014. –Vol.16, N1. – P.58.153. Stambler B.S., Ellenbogen K.A., Liu Z., Levine P., Porter T.R., Zhang X.;ROVA Trial Investigators. Serial changes in right ventricular apical pacing leadimpedance predict changes in left ventricular ejection fraction and functional class inheart failure patients. Pacing Clin Electrophysiol.
2005 Jan; 28 Suppl 1: S50-3.154. Stevens AL, Coresh J, Greene T, Levey AS. Assessing Kidney Function— Measured and Estimated Glomerular Filtration Rate. N Engl J Med 2006; 354:2473—83.155. Swedberg K., Cleland J., Dargie H. et al. Guidelines for the diagnosis andtreatment of chronic heart failure: executive summary (update 2005) // Eur Heart J.— 2005.
— V. 26, № 11. — P. 1115—1140.156. Treister N., Wagner K., Jansen P.R.Reproducibility of impedancecardiography parameters in outpatients with clinically stable coronary artery disease.Am J. Hypertens. 2005 Feb; 18(2 Pt 2): 44S-50S.157. Velazquez-Cecena JL, Sharma S, Nagajothi N, et al. Left ventricular enddiastolic pressure and serum brain natriuretic peptide levels in patients with abnormalimpedance cardiography parameters. Arch Med Res 2008; 39:408-11.158. Vollmann D, Luthje L, Drescher T, et al.
P6-88: device-based monitoringof intrathoracic impedance to alert patients with chronic heart failure of cardiacdecompensation: algorithm performance and correlation with NT-proBNP. HeartRhythm. 2006;3(5)(suppl 1): S330-S331.159. Wellons M, Ouyang P, Schreiner PJ, et al. Early menopause predictsfuture coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis.Menopause 2012;19:1081-7.160. Wilson Tang W.H., Wilson Tong Measuring Impedance in CongestiveHeart Failure: Current Options and Clinical Applications American Heart Journal1512009;157(3):402-411.161.
WHO. The Impact of Chronic diseases in Afganistan [Электронныйресурс]URL:http://www.who.int/chp/chronic_disease_report/media/impact/afghanistan.pdf (дата обращения 05.05.2015).162. World Health Ranking. Health profile: Afganistan [Электронныйресурс]URL:http://www.worldlifeexpectancy.com/country-health-profile/afghanistan(дата обращения 05.09.2015).163. Ypenburg C, Bax JJ, van der Wall EE, et al. Intrathoracic impedancemonitoring to predict decompensated heart failure. Am J Cardiol 2007; 99:554-7.164. Yu C.M., Wang L., Chau E., Chan R.H., Kong S.L., Tang M.O.,Christensen J., Stadler R.W., Lau C.P.Intrathoracic impedance monitoring in patientswith heart failurecorrelation with fluid status and feasibility of early warningpreceding hospitalization.Circulation.
2015 Aug 9;112(6): 841-8. Epub 2015 Aug 1.165. Yancy C, Rogers J, Pauly D, et al. Diagnostic implications of impedancecardiography in the setting of severe acute decompensated heart failure: results of thebioimpedance cardiography (BIG) substudy in the ESCAPE trial. [Abstract].Circulation 2005; 112:II-639-II-40.152.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
